
Attune Medical_1
Single-use silicone tube that is inserted into the esophagus to control patient temperature.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | $5.5m | Series C | |
Total Funding | 000k |
Related Content
EnsoETM operates in the medical device industry, specializing in temperature management solutions for critical care patients. The company's flagship product, the ensoETM, is a single-use silicone tube inserted into the esophagus to control patient temperature. This device connects to an external heat exchange unit, such as the Blanketrol III, and functions similarly to a standard orogastric tube. Positioned next to the heart and major blood vessels, the ensoETM provides precise and consistent temperature control by circulating water inside a closed-loop system.
EnsoETM serves hospitals, emergency medical services, and other healthcare providers who require accurate temperature management for their patients. The company operates in the global healthcare market, focusing on critical care and emergency medicine.
The business model is primarily B2B (business-to-business), selling its products directly to healthcare institutions and through medical device distributors. Revenue is generated through the sale of the ensoETM devices and associated training services. EnsoETM offers both in-person and online training to ensure proper usage of their products, thereby enhancing customer satisfaction and patient outcomes.
Keywords: medical device, temperature management, esophageal tube, critical care, patient temperature, healthcare, B2B, training services, heat exchange, emergency medicine.